2024-03-22
Cholangiocarcinoma in real life
Oncology
Cholangiocarcinoma is a rare and aggressive hepatobiliary malignancy, whose incidence is increasing and for which treatment options are developing. Yet real-life data are lacking to better address the clinical challenges of this tumor. In this multicenter study, researchers analyzed data from 120 patients with metastatic cholangiocarcinoma, with a mean age of 68.5 years. In 65.8% of cases, intrahepatic tumours predominated. Among the 85 patients treated with first-line chemotherapy, cisplatin and gemcitabine were the most common regimens. After a median follow-up of 14 months, 81 cholangiocarcinoma-related deaths were recorded, with a median survival of 13.1 months.

Last press reviews
Genes and Alzheimer’s: the key to the mystery?

#Alzheimer #Genetics #Neurodegeneration #PrecisionMedi...
Postoperative delirium: does melatonin really work?

#Delirium #Surgery #Melatonin #Prevention #Cogni...
Vitamin D deficiency: a risk for the mind?

#Suicide #VitaminD #Depression #Neuroprotection ...